Predictors of clinical virulence in community-onset methicillin-resistant staphylococcus aureus infections: The importance of USA300 and Pneumonia

Clinical Infectious Diseases

Volumn 53, Issue 8, 2011, Pages 757-765

  Hota, Bala ^a,b   Lyles, Rosie ^b   Rim, Jean ^a   Popovich, Kyle J ^a   Rice, Thomas ^b   Aroutcheva, Alla ^a,b   Weinstein, Robert A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Cook County Health and Hospitals System ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL VIRULENCE; COMMUNITY ONSET METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PNEUMONIA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PNEUMONIA, STAPHYLOCOCCAL; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RISK FACTORS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; UNITED STATES; VIRULENCE; YOUNG ADULT;

EID: 80052895354     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir472     Document Type: Article

References (54)

1. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666-74.
2. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763-71. (Pubitemid 47598444)
3. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352:1445-53. (Pubitemid 40471452)
4. Lin MY, Rezai K, Schwartz DN. Septic pulmonary emboli and bacteremia associated with deep tissue infections caused by communityacquired methicillin-resistant Staphylococcus aureus? J Clin Microbiol 2008; 46:1553-5. (Pubitemid 351563617)
5. Gonzalez BE, Teruya J, Mahoney DH Jr, et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics 2006; 117:1673-9. (Pubitemid 46071396)
6. Kravitz GR, Dries DJ, Peterson ML, Schlievert PM. Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 2005; 40:941-7. (Pubitemid 40418298)
7. Adem PV, Montgomery CP, Husain AN, et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med 2005; 353:1245-51. (Pubitemid 41345946)
8. Agwu A, Brady KM, Ross T, Carroll KC, Halsey NA. Cholera-like diarrhea and shock associated with community-acquired methicillinresistant Staphylococcus aureus (USA400 clone) pneumonia. Pediatr Infect Dis J 2007; 26:271-3. (Pubitemid 46340782)
9. Boussaud V, Parrot A, Mayaud C, et al. Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus. Intensive Care Med 2003; 29:1840-3. (Pubitemid 37373837)
10. Dickson RP, Martinez SM, Ortiz JR. A case of rapidly progressive necrotizing pneumonia caused by community-acquired methicillinresistant Staphylococcus aureus. Respir Care 2008; 53:1223-6.
11. Ebert MD, Sheth S, Fishman EK. Necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus: an increasing cause of "mayhem in the lung". Emerg Radiol 2009; 16:159-62.
12. Francis JS, Doherty MC, Lopatin U, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005; 40:100-7. (Pubitemid 40053465)
13. Gillet Y, Vanhems P, Lina G, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 2007; 45:315-21. (Pubitemid 47101027)
14. Gonzalez BE, Hulten KG, Dishop MK, et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis 2005; 41:583-90. (Pubitemid 41170343)
15. Jung N, Lehmann C, Hellmann M, et al. Necrotizing pneumonia caused by Panton-Valentine leucocidin-producing Staphylococcus aureus originating from a Bartholin's abscess. Infect Dis Obstet Gynecol 2008; 2008:491401.
16. Kallen AJ, Brunkard J,Moore Z, et al. Staphylococcus aureus communityacquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med 2009; 53:358-65.
17. Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007; 315:1130-3. (Pubitemid 46328024)
18. Mongkolrattanothai K, Boyle S, Kahana MD, Daum RS. Severe Staphylococcus aureus infections caused by clonally related communityacquired methicillin-susceptible and methicillin-resistant isolates. Clin Infect Dis 2003; 37:1050-8. (Pubitemid 37323659)
19. Obed A, Schnitzbauer AA, Bein T, Lehn N, Linde HJ, Schlitt HJ. Fatal pneumonia caused by Panton-Valentine leucocidine-positive methicillin-resistant Staphylococcus aureus (PVL-MRSA) transmitted from a healthy donor in living-donor liver transplantation. Transplantation 2006; 81:121-4. (Pubitemid 43122159)
20. Reichert B, Birrell G, Bignardi G. Severe non-pneumonic necrotising infections in children caused by Panton-Valentine leukocidin producing Staphylococcus aureus strains. J Infect 2005; 50:438-42. (Pubitemid 40692030)
21. Roberts JC, Gulino SP, Peak KK, Luna VA, Sanderson R. Fatal necrotizing pneumonia due to a Panton-Valentine leukocidin positive community-associated methicillin-sensitive Staphylococcus aureus and influenza co-infection: a case report. Ann Clin Microbiol Antimicrob 2008; 7:5.
22. Murray RJ, Robinson JO, White JN, et al. Community-acquired pneumonia due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection. PLoS One 2010; 5:e8705.
23. Kallen AJ, Reed C, Patton M, Arnold KE, Finelli L, Hageman J. Staphylococcus aureus community-onset pneumonia in patients admitted to children's hospitals during autumn and winter of 2006-2007. Epidemiol Infect 2010; 138:1-7.
24. Vardakas KZ, Matthaiou DK, Falagas ME. Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia. Eur Respir J 2009; 34:1148-58.
25. HidronAI, LowCE, HonigEG, BlumbergHM.Emergence of communityacquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia. Lancet Infect Dis 2009; 9:384-92.
26. Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008; 122:805-11.
27. Tong SY, Anstey NM, Lum GD, Lilliebridge RA, Stephens DP, Currie BJ. Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia after influenza. Med J Aust 2008; 188:61.
28. Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza-Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 2007; 56:325-9.
29. Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006; 12:894-9. (Pubitemid 43848409)
30. Drug-resistant staph: what you need to know-Well Blog-NYTimes .com. 2009. Available at: http://well.blogs.nytimes.com/2007/10/23/drug-resistant-staph- what-you-need-to-know/?ref5health&apage52. Accessed 10 April 2009.
31. Deadly bacteria defy drugs, alarming doctors-chicagotribune.com. 2009. Available at: http://www.chicagotribune.com/news/local/la-sci-badbugs17- 2009feb17,0,174757.story. Accessed 10 April 2009.
32. CA-MRSA outbreaks. 2009. Available at:http://www.medscape.com/ viewarticle/582253-2. Accessed 10 April 2009.
33. Diep BA, Carleton HA, Chang RF, Sensabaugh GF, Perdreau-Remington F. Roles of 34 virulence genes in the evolution of hospital-and communityassociated strains of methicillin-resistant Staphylococcus aureus. J InfectDis 2006; 193:1495-503. (Pubitemid 43794577)
34. Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006; 367:731-9. (Pubitemid 43326291)
35. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 2007; 13:1405-6. (Pubitemid 350224232)
36. Bubeck Wardenburg J, Schneewind O. Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 2008; 205:287-94. (Pubitemid 351281594)
37. Wang R, Braughton KR, Kretschmer D, et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007; 13:1510-4. (Pubitemid 350224240)
38. Li M, Diep BA, Villaruz AE, et al. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 2009; 106:5883-8.
39. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352:1436-44.
40. Popovich KJ, Weinstein RA, Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis 2008; 46:787-94. (Pubitemid 351417176)
41. Hota B, Ellenbogen C, Hayden MK, Aroutcheva A, Rice TW, Weinstein RA. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission? Arch Intern Med 2007; 167:1026-33. (Pubitemid 46835790)
42. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45:613-9.
43. Hota B, Weinstein RA. Performance of an electronic rule (eRule) for surveillance of community-acquired (CA) methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) Staphylococcus aureus. Emerg Infect Dis 2006; 12:1469-71.
44. Kloos W, Bannerman T. Staphylococcus and micrococcus. In: Murray P, Baron E, Pfaller M, Tenover F, Yolken R eds: Manual of Clinical Microbiology, 7th ed. Washington, DC: American Society of Microbiology, 1999.
45. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29:1128-32. (Pubitemid 30265628)
46. Matushek MG, Bonten MJ, Hayden MK. Rapid preparation of bacterial DNA for pulsed-field gel electrophoresis. J Clin Microbiol 1996; 34: 2598-600. (Pubitemid 26307821)
47. Okuma K, Iwakawa K, Turnidge JD, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002; 40:4289-94. (Pubitemid 35285827)
48. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46:2155-61. (Pubitemid 34665910)
49. Lobo LJ, Reed KD, Wunderink RG. Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumonia. Chest 2010; 138:130-6.
50. Fowler VG, Nelson CL, McIntyre LM, et al. Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J Infect Dis 2007; 196:738-47. (Pubitemid 47293857)
51. Montgomery CP, Boyle-Vavra S, Adem PV, et al. Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J Infect Dis 2008; 198:561-70.
52. Lee MH, Arrecubieta C, Martin FJ, Prince A, Borczuk AC, Lowy FD. A postinfluenza model of Staphylococcus aureus pneumonia. J Infect Dis 2010; 201:508-15.
53. Lalani T, Federspiel JJ, Boucher HW, et al. Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients. J Clin Microbiol 2008; 46:2890-6.
54. Ganga R, Riederer K, Sharma M, et al. Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center. J Clin Microbiol 2009; 47:590-5.